Genetic Toxicology

Inotiv, has recently acquired BioReliance Genetox assets as a strategic fit into our portfolio, click here to see press release. Using this as a starting base, Inotiv will offer a Genetic Toxicology Program with a battery of validated genetic toxicology in vitro cell-based assays and in vivo assays to meet ICH, OECD, EFSA, FDA, and EPA guidelines and testing requirements. The program also customizes services to meet clients’ individualized testing needs and provides issue resolution follow-on strategies.

We are currently offering non-GLP studies and are ramping up our GLP services to deliver a full core battery of tests soon. As we continue to add services, please contact us to discuss your needs.

DMPK DMPK Whatever you need, from method development to metabolite ID, our phase-appropriate bioanalytical services help you analyze, answer, and advance.

Histology Histology Our industry-leading histology laboratories support your discovery and nonclinical development projects with a wide range of services. From tissue processing to digital analysis, our team delivers the quality you expect.

Pathology Pathology Access world-class anatomical, clinical, and medical device pathology services, from routine histochemistry, IHC, IF, and ISH to stereology.

In Vivo Services In Vivo Services From discovery to regulatory-enabling safety assessments in advanced developmental and reproductive toxicology (DART), we have the in vivo services and associated bioanalysis capabilities you need to find answers.

Consulting Consulting Our experts deliver the insights you deserve to get the answers you need, whether in DMPK data analysis, biomarker analysis, or bioequivalence studies.